Correlation of global microRNA expression with basal cell carcinoma subtype

G3: Genes, Genomes, Genetics

Volumn 2, Issue 2, 2012, Pages 279-286

  Heffelfinger, Christopher ^a   Ouyang, Zhengqing ^b,c   Engberg, Anna ^d   Leffell, David J ^e   Hanlon, Allison M ^d   Gordon, Patricia B ^d   Zheng, Wei ^a   Zhao, Hongyu ^d   Snyder, Michael P ^b   Bale, Allen E ^d,e  

^a YALE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE CANCER CENTER   (United States)

Author keywords

Expression profiling; Histopathology; miR 150; miR 183; Skin cancer

Indexed keywords

EID: 84871564917     PISSN: None     EISSN: 21601836     Source Type: Journal    
DOI: 10.1534/g3.111.001115     Document Type: Article

References (60)

1. Abraham, D., N. Jackson, J. S. Gundara, J. Zhao, A. J. Gill et al., 2011 MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin. Cancer Res. 17: 4772-4781.
2. Alexa, A., J. Rahnenfuhrer, and T. Lengauer, 2006 Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600-1607.
3. Asplund, A., M. Gry Bjorklund, C. Sundquist, S. Stromberg, K. Edlund, et al. 2008 Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma. Br. J. Dermatol. 158: 527-538.
4. Bandres, E., E. Cubedo, X. Agirre, R. Malumbres, R. Zarate, et al. 2006 Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5: 29.
5. Benjamini, Y., and Y. Hochberg, 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57: 289-300.
6. Bodak, N., S. Queille, M. F. Avril, B. Bouadjar, C. Drougard, et al. 1999 High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc. Natl. Acad. Sci. U S A 96: 5117-5122.
7. Boulinguez, S., C. Grison-Tabone, L. Lamant, S. Valmary, R. Viraben, et al. 2004 Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br. J. Dermatol. 151: 623-626.
8. Carr, R. A., S. M. Taibjee, and D. S. A. Sanders, 2007 Basaloid skin tumors: Basal cell carcinoma. Curr. Diagn. Pathol. 13: 252-272.
9. Dixon, A. Y., S. H. Lee, and D. H. McGregor, 1991 Histologic evolution of basal cell carcinoma recurrence. Am. J. Dermatopathol. 13: 241-247.
10. Elson-Schwab, I., A. Lorentzen, and C. J. Marshall, 2010 MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS ONE 5: pii: e13176.
11. Epstein, E. H., 2008 Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer 8: 743-754.
12. Farazi, T. A., J. I. Spitzer, P. Morozov, and T. Tuschl, 2011 miRNAs in human cancer. J. Pathol. 223: 102-115.
13. Gailani, M. R., D. J. Leffell, A. Ziegler, E. G. Gross, D. E. Brash, et al. 1996a Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J. Natl. Cancer Inst. 88: 349-354.
14. Gailani, M. R., M. Stahle-Backdahl, D. J. Leffell, M. Glynn, P. G. Zaphiropoulos, et al. 1996b The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat. Genet. 14: 78-81.
15. Gallagher, R. P., B. Ma, D. I. McLean, C. P. Yang, V. Ho, et al. 1990 Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J. Am. Acad. Dermatol. 23: 413-421.
16. Griffiths-Jones, S., 2010 miRBase: microRNA sequences and annotation. Curr. Protoc. Bioinformatics Chapter 12: Unit 12.9.1-10.
17. Han, Y., J. Chen, X. Zhao, C. Liang, Y. Wang, et al. 2011 MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 6: e18286.
18. Hannuksela-Svahn, A., E. Pukkala, and J. Karvonen, 1999 Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch. Dermatol. 135: 781-786.
19. Harris, M. A., J. Clark, A. Ireland, J. Lomax, M. Ashburner, et al. 2004 The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32: D258-D261.
20. He, L., and G. J. Hannon, 2004 MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5: 522-531.
21. Heimberg, A. M., L. F. Sempere, V. N. Moy, P. C. Donoghue, and K. J. Peterson, 2008 MicroRNAs and the advent of vertebrate morphological complexity. Proc. Natl. Acad. Sci. U S A 105: 2946-2950.
22. Howell, B. G., N. Solish, C. Lu, H. Watanabe, A. J. Mamelak, et al. 2005 Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior. J. Dermatol. Sci. 39: 39-51.
23. Huang, Y., X. J. Shen, Q. Zou, S. P. Wang, S. M. Tang, et al. 2011 Biological functions of microRNAs: a review. J. Physiol. Biochem. 67: 129-139.
24. Hui, A. B., M. Lenarduzzi, T. Krushel, L. Waldron, M. Pintilie,, et al. 2010 Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16: 1129-1139.
25. Imanaka, Y., S. Tsuchiya, F. Sato, Y. Shimada, K. Shimizu, et al. 2011 MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J. Hum. Genet. 56: 270-276.
26. Jones, M. S., M. E. Maloney, and E. M. Billingsley, 1998 The heterogeneous nature of in vivo basal cell carcinoma. Dermatol. Surg. 24: 881-884.
27. Karagas, M. R., E. R. Greenberg, S. K. Spencer, T. A. Stukel, and L. A. Mott, 1999 Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int. J. Cancer 81: 555-559.
28. Krek, A.,D.Grun, M.N. Poy, R. Wolf, L. Rosenberg, et al. 2005 Combinatorial microRNA target predictions. Nat. Genet. 37: 495-500.
29. Lang, P. G. Jr., and J. C. Maize, 1986 Histologic evolution of recurrent basal cell carcinoma and treatment implications. J. Am. Acad. Dermatol. 14: 186-196.
30. Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, et al. 2003 The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
31. Levi, F., V. C. Te, L. Randimbison, G. Erler, and C. La Vecchia, 2001 Trends in skin cancer incidence in Vaud: an update, 1976-1998. Eur. J. Cancer Prev. 10: 371-373.
32. Lewis, B. P., C. B. Burge, and D. P. Bartel, 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
33. Livak, K. J., and T. D. Schmittgen, 2001 Analysis of relative gene expression using real time quantitative PCR and the 2(-Delta Delta C(T))) method. Methods 25: 402-408.
34. Lowery, A. J., N. Miller, R. M. Dwyer, and M. J. Kerin, 2010 Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 10: 502.
35. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, et al. 2005 MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
36. Martens-Uzunova, E. S., S. E. Jalava, N. F. Dits, G. J. van Leenders, S. Moller, et al. 2011 Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene. doi: 10.1038/onc.2011.304.
37. Meng, F., R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob, et al. 2007 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
38. Netscher, D. T., M. Leong, I. Orengo, D. Yang, C. Berg, et al. 2011 Cutaneous malignancies: melanoma and nonmelanoma types. Plast. Reconstr. Surg. 127: 37e-56e.
39. O'Driscoll, L., J. McMorrow, P. Doolan, E. McKiernan, J. P. Mehta, et al. 2006 Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol. Cancer 5: 74.
40. Reifenberger, J., M. Wolter, C. B. Knobbe, B. Kohler, A. Schonicke, et al. 2005 Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br. J. Dermatol. 152: 43-51.
41. Rippey, J. J., 1998 Why classify basal cell carcinomas?. Histopathology 32: 393-398.
42. Robinson, M. D., D. J. McCarthy, and G. K. Smyth, 2010 edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
43. Rogers, H. W., M. A. Weinstock, A. R. Harris, M. R. Hinckley, S. R. Feldman, et al. 2010 Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 146: 283-287.
44. Saldanha, G., A. Fletcher, and D. N. Slater, 2003 Basal cell carcinoma: a dermatopathological and molecular biological update. Br. J. Dermatol. 148: 195-202.
45. Saydam, O., Y. Shen, T. Wurdinger, O. Senol, E. Boke, et al. 2009 Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol. Cell. Biol. 29: 5923-5940.
46. Schramedei, K., N. Morbt, G. Pfeifer, J. Lauter, M. Rosolowski, et al. 2011 MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30: 2975-2985.
47. Sellheyer, K., 2011 Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers. Br. J. Dermatol. 164: 696-711.
48. Sexton, M., D. B. Jones, and M. E. Maloney, 1990 Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J. Am. Acad. Dermatol. 23: 1118-1126.
49. Shenouda, S. K., and S. K. Alahari, 2009 MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 28: 369-378.
50. Sidransky, D., 1996 Is human patched the gatekeeper of common skin cancers? Nat. Genet. 14: 7-8.
51. Smyth, G. K., J. Michaud, and H. S. Scott, 2005 Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
52. Tsuchiya, S., T. Fujiwara, F. Sato, Y. Shimada, E. Tanaka, et al. 2011 MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 286: 420-428.
53. Wang, G., W. Mao, and S. Zheng, 2008 MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett. 582: 3663-3668.
54. Wang, W. C., F. M. Lin, W. C. Chang, K. Y. Lin, H. D. Huang, et al. 2009 miRExpress: analyzing high-throughput sequencing data for profiling microRNA expression. BMC Bioinformatics 10: 328.
55. Wu, Q., R. Guo, M. Lin, B. Zhou, and Y. Wang, 2011 MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Gynecol. Oncol. 122: 149-154.
56. Xia, H., S. S. Ng, S. Jiang, W. K. Cheung, J. Sze, et al. 2010 miR-200amediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem. Biophys. Res. Commun. 391: 535-541.
57. Xie, J., M. Murone, S. M. Luoh, A. Ryan, Q. Gu, et al. 1998 Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92.
58. Youssef, Y. M., N. M. White, J. Grigull, A. Krizova, C. Samy, et al. 2011 Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur. Urol. 59: 721-730.
59. Yu, M., D. Zloty, B. Cowan, J. Shapiro, A. Haegert, et al. 2008 Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J. Invest. Dermatol. 128: 1797-1805.
60. Ziegler, A., D. J. Leffell, S. Kunala, H. W. Sharma, M. Gailani, et al. 1993 Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. U S A 90: 4216-4220.